首页 > 最新文献

Opuholi Golovy i Sei最新文献

英文 中文
Первая линия лекарственной терапии плоскоклеточного рака головы и шеи. Оптимальная стратегия 头部和颈部平面细胞癌的第一道治疗方法。最佳策略
Q4 Medicine Pub Date : 2019-01-12 DOI: 10.17650/2222-1468-2018-8-4-14-20
Л. В. Болотина, А. Л. Корниецкая, Андрей Дмитриевич Каприн, Е. Ю. Карпенко
The study objective is to provide a rationale for the development of an individual treatment plan for patients with locally advanced squamous cell carcinoma of the larynx, hypopharynx, and oropharynx by selecting different regimens of induction chemotherapy according to biological characteristics of the tumor and functional status of the patient. Materials and methods . We developed an individual treatment plan for a patient with stage IV moderately differentiated oropharyngeal squamous cell carcinoma (cT4N2M0) characterized by extensive local distribution, pronounced clinical symptoms of respiratory failure, and bilateral conglomerates of metastatic lymph nodes. The treatment scheme included paclitaxel (80 mg/m 2 ), carboplatin AUC 2, and ce-tuximab (400 mg/m 2 loading dose, then 250 mg/m 2 ). The treatment was initially palliative. The patient received 6 injections once a week. Results. After a six-week course, we observed tumor resorption by more than 50 %, which allowed the second stage of treatment that included radical chemoradiotherapy with cetuximab. After summarizing our own experience, we found that the majority of patients with initially unresectable tumors, but in good overall physical condition responded to docetaxel, cisplatin, 5-fluorouracil (TPF) — based chemotherapy. Approximately half of them had complete tumor resorption, whereas 14.2 % of them had stabilization of the tumor process. Research literature shows that up to 30 % of patients receiving chemoradiotherapy with cisplatin fail to complete the planned treatment due to its toxicity; replacement of cisplatin with carboplatin and 5-fluorouracil results in mucositis and thrombocytopenia. By contrast, chemoradiotherapy with cetuximab significantly increases both 3-year and 5-year survival and demonstrates good tolerability. In patients with .severe nutritional deficiency, concomitant cardiac diseases, polyneuropathy, and impaired liver function, the preference should be given to less toxic treatment regimens. Conclusion. Cetuximab-containing chemotherapy regimens are the most effective treatment option in head and neck squamous cell carcinoma They can be used in patients with different functional status depending on the clinical situation.
本研究的目的是根据肿瘤的生物学特点和患者的功能状况,选择不同的诱导化疗方案,为喉部、下咽、口咽局部晚期鳞状细胞癌患者制定个体化治疗方案提供依据。材料和方法。我们为一位IV期中度分化口咽鳞状细胞癌(cT4N2M0)患者制定了一项个体化治疗计划,其特征是广泛的局部分布、明显的呼吸衰竭临床症状和双侧转移性淋巴结聚集。治疗方案包括紫杉醇(80 mg/ m2)、卡铂AUC 2和西妥昔单抗(负载剂量为400 mg/ m2,然后是250 mg/ m2)。这种治疗最初只是治标不治本。患者每周注射6次。结果。经过六周的疗程,我们观察到肿瘤吸收超过50%,这允许第二阶段的治疗,包括西妥昔单抗根治性放化疗。在总结自身经验后,我们发现大多数患者最初无法切除肿瘤,但整体身体状况良好,对多西紫杉醇、顺铂、5-氟尿嘧啶(TPF)为主的化疗有反应。大约一半的患者肿瘤完全吸收,而14.2%的患者肿瘤进程稳定。研究文献显示,多达30%的接受顺铂放化疗的患者由于其毒性而未能完成计划的治疗;用卡铂和5-氟尿嘧啶代替顺铂会导致粘膜炎和血小板减少症。相比之下,西妥昔单抗放化疗可显著提高3年和5年生存率,并表现出良好的耐受性。对于伴有严重营养缺乏、心脏病、多发性神经病变和肝功能受损的患者,应优先考虑毒性较小的治疗方案。结论。含西妥昔单抗的化疗方案是头颈部鳞状细胞癌最有效的治疗方案,可根据临床情况对不同功能状态的患者进行治疗。
{"title":"Первая линия лекарственной терапии плоскоклеточного рака головы и шеи. Оптимальная стратегия","authors":"Л. В. Болотина, А. Л. Корниецкая, Андрей Дмитриевич Каприн, Е. Ю. Карпенко","doi":"10.17650/2222-1468-2018-8-4-14-20","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-4-14-20","url":null,"abstract":"The study objective is to provide a rationale for the development of an individual treatment plan for patients with locally advanced squamous cell carcinoma of the larynx, hypopharynx, and oropharynx by selecting different regimens of induction chemotherapy according to biological characteristics of the tumor and functional status of the patient. Materials and methods . We developed an individual treatment plan for a patient with stage IV moderately differentiated oropharyngeal squamous cell carcinoma (cT4N2M0) characterized by extensive local distribution, pronounced clinical symptoms of respiratory failure, and bilateral conglomerates of metastatic lymph nodes. The treatment scheme included paclitaxel (80 mg/m 2 ), carboplatin AUC 2, and ce-tuximab (400 mg/m 2 loading dose, then 250 mg/m 2 ). The treatment was initially palliative. The patient received 6 injections once a week. Results. After a six-week course, we observed tumor resorption by more than 50 %, which allowed the second stage of treatment that included radical chemoradiotherapy with cetuximab. After summarizing our own experience, we found that the majority of patients with initially unresectable tumors, but in good overall physical condition responded to docetaxel, cisplatin, 5-fluorouracil (TPF) — based chemotherapy. Approximately half of them had complete tumor resorption, whereas 14.2 % of them had stabilization of the tumor process. Research literature shows that up to 30 % of patients receiving chemoradiotherapy with cisplatin fail to complete the planned treatment due to its toxicity; replacement of cisplatin with carboplatin and 5-fluorouracil results in mucositis and thrombocytopenia. By contrast, chemoradiotherapy with cetuximab significantly increases both 3-year and 5-year survival and demonstrates good tolerability. In patients with .severe nutritional deficiency, concomitant cardiac diseases, polyneuropathy, and impaired liver function, the preference should be given to less toxic treatment regimens. Conclusion. Cetuximab-containing chemotherapy regimens are the most effective treatment option in head and neck squamous cell carcinoma They can be used in patients with different functional status depending on the clinical situation.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"14-20"},"PeriodicalIF":0.0,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Устранение нарушений голосовой функции при открытых диагональных резекциях гортани 修复喉咙开放式对角线切开术中的语音功能障碍
Q4 Medicine Pub Date : 2019-01-12 DOI: 10.17650/2222-1468-2018-8-4-32-38
А. Л. Кожанов, Л. Г. Кожанов, Вадим Николаевич Сорокин, Е. С. Романова
The study objective is to perform the acoustic analysis of voice in patients after open diagonal resection of the larynx. Materials and methods . A total of 112 patients underwent diagonal resection of the larynx; of them 73 hadfrontolateral resection and 39 had expanded frontolateral resection. Primary laryngeal cancer was diagnosed in 107 patients; five patients had relapses after radiation therapy. Fifty-six participants underwent acoustic analysis of voice before surgery, 52 participants underwent it 1 month postoperatively, and 112 participants had it after completing their rehabilitation (6 months to 10 years postoperatively). To determine normal acoustic characteristics of voice, we examined 80 men with normal voice. We measured voice fundamental frequency (FF), maximum and minimum FF, FF variability, jitter, shimmer, voice intensity, amplitude of fundamental tone’s harmonics and their difference. Speech rehabilitation included breathing exercises according to E. Ya. Zolotareva and speech training according to S.L. Taptapova. Results. Patients with laryngeal cancer demonstrated significant changes in the acoustic characteristics of their voice (p <0.05) compared to healthy individuals, including increased mean FF (f 0 ) (up to 143 ± 45 Hz vs 118 ± 18 Hz in controls), decreased voice intensity (from 60 ± 8 to 43 ± 8 d B), and almost 2-fold decrease in the amplitude of fundamental tone’s harmonics (ω 0 , 2 ω 0 , 3 ω 0 ). We also found an increased dispersion and variability of acoustic characteristics assessed compared to healthy individuals. The analysis of long-term treatment outcomes demonstrated more significant improvement of voice acoustic characteristics in patients who underwent speech rehabilitation compared to those who had no rehabilitation. Conclusion. Open resection of the larynx with endoscopic removal of granulations and ligatures and laser restoration of the laryngeal lumen by dissecting the scars complemented by speech rehabilitation allow restoring respiratory function in 91.1 % of patients and restoring voice in 91.8 % of patients (to achieve acoustic characteristics close to normal).
本研究的目的是对开放性对角喉切除术后患者的声音进行声学分析。材料和方法。112例患者行喉部对角切除;其中73例行额外侧切除术,39例行扩大额外侧切除术。原发性喉癌107例;5例患者放射治疗后复发。56名参与者在手术前进行了声音分析,52名参与者在术后1个月进行了声音分析,112名参与者在完成康复后(术后6个月至10年)进行了声音分析。为了确定正常声音的声学特征,我们对80名正常声音的男性进行了检查。我们测量了声音基频(FF)、最大和最小FF、FF变异性、抖动、闪烁、声音强度、基频谐波幅值及其差异。根据E. Ya的说法,语言康复包括呼吸练习。Zolotareva和Taptapova的语言训练。结果。与健康个体相比,喉癌患者的声音声学特征发生了显著变化(p <0.05),包括平均FF (f 0)增加(高达143±45 Hz,对照组为118±18 Hz),声音强度下降(从60±8到43±8 d B),基本音谐波幅度下降近2倍(ω 0, 2 ω 0, 3 ω 0)。我们还发现,与健康个体相比,声学特征的分散和变异性有所增加。对长期治疗结果的分析表明,接受语言康复治疗的患者的声音声学特征比未接受康复治疗的患者有更显著的改善。结论。内镜下切开喉部切除肉芽结扎,激光切开瘢痕修复喉腔,辅以语言康复,91.1%的患者呼吸功能恢复,91.8%的患者声音恢复(声学特征接近正常)。
{"title":"Устранение нарушений голосовой функции при открытых диагональных резекциях гортани","authors":"А. Л. Кожанов, Л. Г. Кожанов, Вадим Николаевич Сорокин, Е. С. Романова","doi":"10.17650/2222-1468-2018-8-4-32-38","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-4-32-38","url":null,"abstract":"The study objective is to perform the acoustic analysis of voice in patients after open diagonal resection of the larynx. Materials and methods . A total of 112 patients underwent diagonal resection of the larynx; of them 73 hadfrontolateral resection and 39 had expanded frontolateral resection. Primary laryngeal cancer was diagnosed in 107 patients; five patients had relapses after radiation therapy. Fifty-six participants underwent acoustic analysis of voice before surgery, 52 participants underwent it 1 month postoperatively, and 112 participants had it after completing their rehabilitation (6 months to 10 years postoperatively). To determine normal acoustic characteristics of voice, we examined 80 men with normal voice. We measured voice fundamental frequency (FF), maximum and minimum FF, FF variability, jitter, shimmer, voice intensity, amplitude of fundamental tone’s harmonics and their difference. Speech rehabilitation included breathing exercises according to E. Ya. Zolotareva and speech training according to S.L. Taptapova. Results. Patients with laryngeal cancer demonstrated significant changes in the acoustic characteristics of their voice (p <0.05) compared to healthy individuals, including increased mean FF (f 0 ) (up to 143 ± 45 Hz vs 118 ± 18 Hz in controls), decreased voice intensity (from 60 ± 8 to 43 ± 8 d B), and almost 2-fold decrease in the amplitude of fundamental tone’s harmonics (ω 0 , 2 ω 0 , 3 ω 0 ). We also found an increased dispersion and variability of acoustic characteristics assessed compared to healthy individuals. The analysis of long-term treatment outcomes demonstrated more significant improvement of voice acoustic characteristics in patients who underwent speech rehabilitation compared to those who had no rehabilitation. Conclusion. Open resection of the larynx with endoscopic removal of granulations and ligatures and laser restoration of the laryngeal lumen by dissecting the scars complemented by speech rehabilitation allow restoring respiratory function in 91.1 % of patients and restoring voice in 91.8 % of patients (to achieve acoustic characteristics close to normal).","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"32-38"},"PeriodicalIF":0.0,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Акнеподобная сыпь - кожная токсическая реакция на применение ингибиторов EGFR 轴向皮疹——对EGFR抑制剂应用的毒性反应
Q4 Medicine Pub Date : 2019-01-12 DOI: 10.17650/2222-1468-2018-8-4-48-55
Е. А. Шатохина, Л. С. Круглова
Introduction. Inhibitors of the epidermal growth factor receptor cause the heavy dermatological adverse events, which can be the cause of change of the scheme of treatment. Acneiform rash is connected with specific inflammation of hair follicles, its weight depends on a dose of medicine and correlates with the best response to therapy at various options of tumors, in this regard effective correction of this side effect is of particular importance. Materials and methods . There were 32 patients with acneiform rash for observation; they have been divided into 3 groups. All patients received system antibacterial therapy: doxycycline 100 mg 2 times a day 10 days and topical medicines for external therapy, various on the action mechanism (tacrolimus, metronidazole, betamethasone valerate in a combination with fusidic acid). Acne Dermatology Index and Dermatology Life Quality Index were used for assessment. The received results were assesed on each visit of the patient, the final point of observations was in 3 months. Results. The significant regression of rash in all groups was in the 1st week when patients accepted doxycycline per os. Further the weakest response to therapy has shown cream with tacrolimus, the patients using gel with metronidazole has shown bigger effect, the fastest regress of Acne Dermatology Index and Dermatology Life Quality Index was observed in the patients used the combined cream with betamethasone and fusidic acid. Conclusions. The antibacterial therapy by doxycycline 100 mg 2 times a day per os at early stages of development of acneiform rash at the I—II severity gives the expressed effect and prevents deterioration of the .skin process. The combined therapy of acneiform rash of the I—II degree including doxycycline with topical cream containing a betamethasone valerate 0.1 % and fusidic acid 20 % renders the fastest and expressed effect in comparison with other combinations: the doxycycline and cream containing tacrolimus; the doxycycline and gel containing metronidazole.
介绍。表皮生长因子受体抑制剂引起严重的皮肤不良事件,这可能是改变治疗方案的原因。痤疮样皮疹与特定的毛囊炎症有关,其重量取决于药物剂量,并与各种肿瘤治疗的最佳反应相关,在这方面有效纠正这种副作用尤为重要。材料和方法。观察32例痤疮样皮疹;他们被分成三组。所有患者均接受系统抗菌治疗:强力霉素100mg,每天2次,10天,外用药物治疗,作用机制不同(他克莫司、甲硝唑、戊酸倍他米松联合夫西地酸)。采用痤疮皮肤病指数和皮肤病生活质量指数进行评价。患者每次访视时对收到的结果进行评估,最后观察时间为3个月。结果。所有组的皮疹均在患者接受强力霉素治疗的第1周显著消退。同时,他克莫司乳膏组疗效最弱,甲硝唑乳膏组疗效较好,倍他米松、夫西地酸联合乳膏组痤疮皮肤病指数和皮肤病生活质量指数恢复最快。结论。在I-II严重程度的痤疮疹发展的早期阶段,多西环素100mg每天2次的抗菌治疗可以达到所表达的效果,并防止皮肤过程的恶化。多西环素与含有0.1%戊酸倍他米松和20%夫西地酸的外用乳膏联合治疗I-II度痤疮疹,与其他联合治疗相比,疗效最快,效果最明显:多西环素与含有他克莫司的乳膏联合治疗;强力霉素和甲硝唑凝胶。
{"title":"Акнеподобная сыпь - кожная токсическая реакция на применение ингибиторов EGFR","authors":"Е. А. Шатохина, Л. С. Круглова","doi":"10.17650/2222-1468-2018-8-4-48-55","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-4-48-55","url":null,"abstract":"Introduction. Inhibitors of the epidermal growth factor receptor cause the heavy dermatological adverse events, which can be the cause of change of the scheme of treatment. Acneiform rash is connected with specific inflammation of hair follicles, its weight depends on a dose of medicine and correlates with the best response to therapy at various options of tumors, in this regard effective correction of this side effect is of particular importance. Materials and methods . There were 32 patients with acneiform rash for observation; they have been divided into 3 groups. All patients received system antibacterial therapy: doxycycline 100 mg 2 times a day 10 days and topical medicines for external therapy, various on the action mechanism (tacrolimus, metronidazole, betamethasone valerate in a combination with fusidic acid). Acne Dermatology Index and Dermatology Life Quality Index were used for assessment. The received results were assesed on each visit of the patient, the final point of observations was in 3 months. Results. The significant regression of rash in all groups was in the 1st week when patients accepted doxycycline per os. Further the weakest response to therapy has shown cream with tacrolimus, the patients using gel with metronidazole has shown bigger effect, the fastest regress of Acne Dermatology Index and Dermatology Life Quality Index was observed in the patients used the combined cream with betamethasone and fusidic acid. Conclusions. The antibacterial therapy by doxycycline 100 mg 2 times a day per os at early stages of development of acneiform rash at the I—II severity gives the expressed effect and prevents deterioration of the .skin process. The combined therapy of acneiform rash of the I—II degree including doxycycline with topical cream containing a betamethasone valerate 0.1 % and fusidic acid 20 % renders the fastest and expressed effect in comparison with other combinations: the doxycycline and cream containing tacrolimus; the doxycycline and gel containing metronidazole.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"48-55"},"PeriodicalIF":0.0,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Динамика качества жизни у пациентов с раком полости рта, перенесших комбинированное/комплексное лечение, и его клиническая значимость 口腔癌患者的生活质量动态,他们接受了综合治疗,并具有临床意义。
Q4 Medicine Pub Date : 2019-01-12 DOI: 10.17650/2222-1468-2018-8-4-39-47
A. Karpenko, R. R. Sibgatullin, A. A. Boyko, M. G. Kostova, O. M. Nikolayeva, E. M. Trunin
The study objective is to evaluate the quality of life as one of the main parameters that determines the effectiveness of treatment of patients with head and neck squamous cell carcinoma. Materials and methods . Thirty-three stage III—IV oral cancer patients aged between 39 and 70 years were asked to fill EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30-questions) and QLQ-H&N35 (head and neck cancer-specific module) before and 12—18 months after completion of the treatment that consisted of surgery followed by radiation with or without chemotherapy. Surgery included neck dissection with removal of the primary tumor via transoral (n = 5) or combined (n = 28) approach. Reconstruction was performed by primary closure (n = 5), with pedicled (n = 8) or free (n = 20) flaps. Results. According to EORTC QLQ-C30 questionnaire only positive shifts turned out to be statistically significant: general health, emotional function, pain, insomnia and diarrhea. Site-specific EORTC QLQ-H&N35 questionnaire revealed several positive (pain in the head and neck, feeling ill, use of painkillers and weight gain) and negative (public eating, problems with taste and smell, sticky saliva and dry mouth) changes. Applying algorithms for determining clinical significance changed the number and value of several scales and domains. Changes in general health, emotional function, pain, insomnia, pain in the head and neck, taste and smell disorders, mouth opening, sticky saliva, dry mouth, painkillers and weight gain were found to have some clinical relevance. Moreover, for one of them (mouth opening) statistical significance was not reached. Conclusions. Further research of clinical significance of changes and differences in scales and domains that determine and affect quality of life are needed. They will allow to understand more fully problems that every patient with oral cavity cancer tries to cope with.
本研究的目的是评价生活质量作为决定头颈部鳞状细胞癌患者治疗效果的主要参数之一。材料和方法。33名年龄在39 - 70岁之间的III-IV期口腔癌患者被要求在完成治疗前和治疗后12-18个月填写EORTC QLQ-C30(欧洲癌症研究与治疗组织生活质量问卷核心30个问题)和QLQ-H&N35(头颈部癌症特异性模块)。手术包括颈部清扫并经口切除原发肿瘤(n = 5)或联合(n = 28)入路。重建通过初级闭合(n = 5),带蒂皮瓣(n = 8)或游离皮瓣(n = 20)进行。结果。根据EORTC QLQ-C30问卷,只有积极的变化在统计上是显著的:一般健康、情绪功能、疼痛、失眠和腹泻。特定地点的EORTC QLQ-H&N35问卷显示了一些积极的(头颈部疼痛,感觉不适,使用止痛药和体重增加)和消极的(公共饮食,味觉和嗅觉问题,唾液粘粘和口干)变化。应用确定临床意义的算法改变了几个尺度和域的数量和值。一般健康状况、情绪功能、疼痛、失眠、头颈疼痛、味觉和嗅觉障碍、张嘴、唾液粘稠、口干、止痛药和体重增加的变化被发现具有一定的临床相关性。此外,其中一个(张嘴)没有达到统计学意义。结论。需要进一步研究决定和影响生活质量的尺度和领域的变化和差异的临床意义。它们将使我们更全面地了解每个口腔癌患者试图应对的问题。
{"title":"Динамика качества жизни у пациентов с раком полости рта, перенесших комбинированное/комплексное лечение, и его клиническая значимость","authors":"A. Karpenko, R. R. Sibgatullin, A. A. Boyko, M. G. Kostova, O. M. Nikolayeva, E. M. Trunin","doi":"10.17650/2222-1468-2018-8-4-39-47","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-4-39-47","url":null,"abstract":"The study objective is to evaluate the quality of life as one of the main parameters that determines the effectiveness of treatment of patients with head and neck squamous cell carcinoma. Materials and methods . Thirty-three stage III—IV oral cancer patients aged between 39 and 70 years were asked to fill EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30-questions) and QLQ-H&N35 (head and neck cancer-specific module) before and 12—18 months after completion of the treatment that consisted of surgery followed by radiation with or without chemotherapy. Surgery included neck dissection with removal of the primary tumor via transoral (n = 5) or combined (n = 28) approach. Reconstruction was performed by primary closure (n = 5), with pedicled (n = 8) or free (n = 20) flaps. Results. According to EORTC QLQ-C30 questionnaire only positive shifts turned out to be statistically significant: general health, emotional function, pain, insomnia and diarrhea. Site-specific EORTC QLQ-H&N35 questionnaire revealed several positive (pain in the head and neck, feeling ill, use of painkillers and weight gain) and negative (public eating, problems with taste and smell, sticky saliva and dry mouth) changes. Applying algorithms for determining clinical significance changed the number and value of several scales and domains. Changes in general health, emotional function, pain, insomnia, pain in the head and neck, taste and smell disorders, mouth opening, sticky saliva, dry mouth, painkillers and weight gain were found to have some clinical relevance. Moreover, for one of them (mouth opening) statistical significance was not reached. Conclusions. Further research of clinical significance of changes and differences in scales and domains that determine and affect quality of life are needed. They will allow to understand more fully problems that every patient with oral cavity cancer tries to cope with.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"39-47"},"PeriodicalIF":0.0,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Необходимость и преимущества персонифицированной шейной лимфодиссекции при раке слизистой оболочки полости рта T1-2N0M0. Путь к радикальной операции T1-2N0M0口腔粘膜癌的个性化颈椎淋巴瘤的需要和好处。激进行动的道路
Q4 Medicine Pub Date : 2019-01-12 DOI: 10.17650/2222-1468-2018-8-4-26-31
Г. Марголин, А. М. Мудунов, Израиль Моисеевич Гельфанд, Ю. В. Алымов, А. А. Ахундов, Сергей Подвязников, М. Н. Нариманов, Т. Н. Заботина, Е. Н. Захарова
The study objective is to investigate the causes of insufficient efficiency of neck lymph node dissection and possibilities of its improvement in cancer of the oral mucosa without clinically detectable metastases. Materials and methods. A review of literature on surgical methods of affecting regional lymph collectors in cancers of the oral cavity was performed, and preliminary data on possibilities of biopsy of the sentinel lymph node were obtained. Conclusion. Combination of fluorescent lymph node mapping andflow cytometry allows to identify the sentinel lymph node and detect hidden micrometastases with high sensitivity.
本研究的目的是探讨颈部淋巴结清扫效率低下的原因,以及在临床上未发现转移的口腔粘膜癌中淋巴结清扫效率提高的可能性。材料和方法。回顾了影响口腔肿瘤区域淋巴收集器的手术方法的文献,并获得了前哨淋巴结活检可能性的初步数据。结论。结合荧光淋巴结作图和流式细胞术可以识别前哨淋巴结,并以高灵敏度检测隐藏的微转移。
{"title":"Необходимость и преимущества персонифицированной шейной лимфодиссекции при раке слизистой оболочки полости рта T1-2N0M0. Путь к радикальной операции","authors":"Г. Марголин, А. М. Мудунов, Израиль Моисеевич Гельфанд, Ю. В. Алымов, А. А. Ахундов, Сергей Подвязников, М. Н. Нариманов, Т. Н. Заботина, Е. Н. Захарова","doi":"10.17650/2222-1468-2018-8-4-26-31","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-4-26-31","url":null,"abstract":"The study objective is to investigate the causes of insufficient efficiency of neck lymph node dissection and possibilities of its improvement in cancer of the oral mucosa without clinically detectable metastases. Materials and methods. A review of literature on surgical methods of affecting regional lymph collectors in cancers of the oral cavity was performed, and preliminary data on possibilities of biopsy of the sentinel lymph node were obtained. Conclusion. Combination of fluorescent lymph node mapping andflow cytometry allows to identify the sentinel lymph node and detect hidden micrometastases with high sensitivity.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"257 1","pages":"26-31"},"PeriodicalIF":0.0,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outlooks on neuropsychological rehabilitation of patients with oropharyngeal cancer 口咽癌患者神经心理康复的展望
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.17650/2222-1468-2018-8-4-68-70
G. Tkachenko, E. I. Skvortsova
{"title":"Outlooks on neuropsychological rehabilitation of patients with oropharyngeal cancer","authors":"G. Tkachenko, E. I. Skvortsova","doi":"10.17650/2222-1468-2018-8-4-68-70","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-4-68-70","url":null,"abstract":"","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67777101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microscopically controlled surgery with three-dimensional histology, tumescent local anesthesia and intracutaneous sutures for high tension in the treatment of skin cancer 显微控制手术,三维组织学,肿胀局部麻醉和皮内缝合治疗高张力皮肤癌
Q4 Medicine Pub Date : 2018-11-08 DOI: 10.17650/2222-1468-2018-8-3-21-36
H. Breuninger, I. A. Belova
The study objectiveis to describe the available techniques of microscopically controlled surgery for skin cancer with histological control of tumor resection margins (three-dimensional (3D) histology). This approach almost completely eliminates the risk of recurrence and allows preserving healthy tissue. It is a standard treatment for skin cancer in Germany; however, in Russia and other CIS countries, this method is not in use.Materials and methods.We reviewed German standards for skin cancer treatment and currently available research literature on the treatment methods used for skin cancer.Results.Automated subcutaneous tumescent local anesthesia (ATLA). Since ATLA contains a highly diluted (up to 100 times) anesthetic, we can inject a 100-fold larger volume, thus, increasing the anesthetized area. The use of naropin or ropivacaine in ATLA ensures long lasting effect (10 h on average), while the incidence of side effects is two times lower due to mixing of anesthetics and reducing their doses. The anesthetic solution is injected slowly; therefore, the patient has neither pain nor oppressive feeling. Moreover, the sodium chloride solution was replaced by ionosteril, which eliminates burning sensation. Microscopically controlled surgery (MCS). Before excision, the tumor is topographically marked (with indicating the 12 o’clock position) in order to determine the tissues that should be additionally excised after finding a tumor infiltrate in the resection margin. The tumor is excised by circumscribing an ellipse of skin; the scalpel blade should be tilted toward the tumor, making an acute angle with skin surface. The defect is closed by wound closure strips; then a compression bandage is placed over the strips. When the complete removal of tumor infiltrates is histologically confirmed, the wound is sutured or closed with a flap (if necessary). MCS ensures complete removal of the tumor and preservation of healthy tissues, which is particularly important for patients with head and neck cancer. Three-dimensional histology. In the case of small tumor specimens (up to 2 cm), the margins and the basis of the specimen are folded to a one plane by incisions (“Muffin” technique). Larger specimens require the “Tubingen cake” technique: a narrow (2–4 mm) lateral strip is cut vertically around the full perimeter of the tumor border (marginal fragment). Then a narrow section is cut from the bottom of the specimen (basal fragment); the remaining tissue is cut by diameter (medial fragment). The marginal and basal fragments are examined to identify tumor infiltrates, whereas the medial fragment is used for the diagnosis. The 3D-histological examination allows revealing twice as many tumor infiltrates as conventional histology in Germany, tumor recurrence is the lowest in the world. 3D-histology does not require additional labor costs. Defect closure using intracutaneous 3D-sutures for high tension. Absorbable butterfly and double butterfly sutures withstand strong
本研究的目的是描述具有肿瘤切除边缘组织学控制(三维(3D)组织学)的皮肤癌显微控制手术的可用技术。这种方法几乎完全消除了复发的风险,并保留了健康组织。在德国,这是治疗皮肤癌的标准方法;然而,在俄罗斯和其他独联体国家,这种方法并没有被使用。材料和方法。我们回顾了德国皮肤癌治疗标准和目前关于皮肤癌治疗方法的研究文献。由于ATLA含有高度稀释(高达100倍)的麻醉剂,我们可以注射100倍的体积,从而增加麻醉面积。在ATLA中使用纳洛平或罗哌卡因可确保长效(平均10小时),同时由于混合麻醉剂和减少剂量,副作用发生率降低了两倍。麻醉溶液缓慢注射;因此,患者既没有疼痛感,也没有压迫感。此外,氯化钠溶液被离子甾醇取代,消除了烧灼感。显微控制手术(MCS)在切除前,对肿瘤进行地形标记(标记12点钟位置),以便在切除边缘发现肿瘤浸润后,确定需要进一步切除的组织。通过在皮肤上画一个椭圆来切除肿瘤;手术刀刀片应向肿瘤倾斜,与皮肤表面成锐角。用创口闭合条闭合缺陷;然后将压缩绷带放在绷带上。当组织学证实肿瘤浸润完全切除时,缝合或用皮瓣缝合伤口(如有必要)。MCS确保了肿瘤的完全切除和健康组织的保存,这对头颈癌患者尤为重要。三维组织学。对于小的肿瘤标本(不超过2厘米),通过切口将边缘和标本的基底折叠成一个平面(“松饼”技术)。较大的标本需要“蒂宾根饼”技术:在肿瘤边缘(边缘碎片)的整个周长周围垂直切割一条狭窄(2-4毫米)的侧边条。然后从标本的底部切出一小段(基底碎片);剩余组织按直径切割(内侧碎片)。检查边缘和基底碎片以确定肿瘤浸润,而内侧碎片用于诊断。在德国,3d组织学检查可以发现两倍于常规组织学的肿瘤浸润,肿瘤复发率是世界上最低的。3d组织学不需要额外的人工成本。使用皮内3d缝合术缝合高张力缺损。可吸收蝶形和双蝶形缝合线可承受强烈的皮肤张力,从而避免局部组织和皮肤移植的重建手术,并避免使用扩张器。这改善了功能和美观的效果,减少了手术时间,术后并发症的发生率,并降低了治疗费用。MCS、3D组织学、ATLA和皮内3D缝合修复高张力缺损可保护健康组织,减少并发症和复发的频率,改善功能和美容效果,缩短手术时间和治疗费用。这种技术在德国已经证明了它的有效性;因此,我们建议在俄罗斯联邦和独联体国家实施。
{"title":"Microscopically controlled surgery with three-dimensional histology, tumescent local anesthesia and intracutaneous sutures for high tension in the treatment of skin cancer","authors":"H. Breuninger, I. A. Belova","doi":"10.17650/2222-1468-2018-8-3-21-36","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-3-21-36","url":null,"abstract":"The study objectiveis to describe the available techniques of microscopically controlled surgery for skin cancer with histological control of tumor resection margins (three-dimensional (3D) histology). This approach almost completely eliminates the risk of recurrence and allows preserving healthy tissue. It is a standard treatment for skin cancer in Germany; however, in Russia and other CIS countries, this method is not in use.Materials and methods.We reviewed German standards for skin cancer treatment and currently available research literature on the treatment methods used for skin cancer.Results.Automated subcutaneous tumescent local anesthesia (ATLA). Since ATLA contains a highly diluted (up to 100 times) anesthetic, we can inject a 100-fold larger volume, thus, increasing the anesthetized area. The use of naropin or ropivacaine in ATLA ensures long lasting effect (10 h on average), while the incidence of side effects is two times lower due to mixing of anesthetics and reducing their doses. The anesthetic solution is injected slowly; therefore, the patient has neither pain nor oppressive feeling. Moreover, the sodium chloride solution was replaced by ionosteril, which eliminates burning sensation. Microscopically controlled surgery (MCS). Before excision, the tumor is topographically marked (with indicating the 12 o’clock position) in order to determine the tissues that should be additionally excised after finding a tumor infiltrate in the resection margin. The tumor is excised by circumscribing an ellipse of skin; the scalpel blade should be tilted toward the tumor, making an acute angle with skin surface. The defect is closed by wound closure strips; then a compression bandage is placed over the strips. When the complete removal of tumor infiltrates is histologically confirmed, the wound is sutured or closed with a flap (if necessary). MCS ensures complete removal of the tumor and preservation of healthy tissues, which is particularly important for patients with head and neck cancer. Three-dimensional histology. In the case of small tumor specimens (up to 2 cm), the margins and the basis of the specimen are folded to a one plane by incisions (“Muffin” technique). Larger specimens require the “Tubingen cake” technique: a narrow (2–4 mm) lateral strip is cut vertically around the full perimeter of the tumor border (marginal fragment). Then a narrow section is cut from the bottom of the specimen (basal fragment); the remaining tissue is cut by diameter (medial fragment). The marginal and basal fragments are examined to identify tumor infiltrates, whereas the medial fragment is used for the diagnosis. The 3D-histological examination allows revealing twice as many tumor infiltrates as conventional histology in Germany, tumor recurrence is the lowest in the world. 3D-histology does not require additional labor costs. Defect closure using intracutaneous 3D-sutures for high tension. Absorbable butterfly and double butterfly sutures withstand strong","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67775761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery for advanced oropharyngeal cancer 晚期口咽癌的外科治疗
Q4 Medicine Pub Date : 2018-11-08 DOI: 10.17650/2222-1468-2018-8-3-37-45
A. Karpenko, R. Sibgatullin, A. A. Boyko, N. Chumanikhina, E. Y. Lomteva, M. V. Lavrova, M. Kostova, O. M. Nikolayeva
The study objectiveis to assess the results of this approach and identifications of factors that may influence the effectiveness of such an approach.Materials and methods. Since 2009 through 2016 72 patients with stage III and IV aged between 42 and 77 years underwent upfront surgery.Anatomical sites included 34 (46 %) tonsil, 24 (33 %) base of tongue and 14 (21 %) soft palate cases. Transcervical sparing the mandible,mandibulectomy and transoral approaches were used in 42 (58 %), 11 (15 %) and 7 (10 %) patient, respectively. Total glossectomy was performed in 4 (5.5 %) cases. Tumor extension necessitated extended laryngectomy in 8 patients (11.5 %). Primary closure of the pharyngeal wound was possible in 30 patients (42 %). Reconstruction with distant flaps was performed in the remaining 42 patients. Both free (anterolateral thigh – 19, radial forearm flap – 10) and flaps with axial blood supply (pectoralis major – 9, supraclavicular flap – 4) were used. There were 6 T1, 12 T2, 28 T3 and 20 T4 tumors; 62 patients were N-positive: N1 – 10 cases, N2 – 51, N3 – 1. Positive surgical margins were diagnosed in 13 cases (18 %) including 3 cases of R2 resection. Adjuvant radiation therapy with or without chemotherapy was completed in 45 patients (63.4 %). Survival was calculated according to Kaplan–Mayer method.Results.There was 1 death in early postoperative period. Mean follow-up for the remaining patients (n = 71) was 27 months (1–94). Median survival was 27 months (95 % CI 11.5–42.5); 3-year overall survival was 44 %; 33 out of 34 still alive patients are capable to take food orally. Only 1 (2.9 %) patient is gastrostomy tube dependent. Univariate analysis revealed that positive margins (p <0.0001) and completeness of combined treatment (p <0.01) are the main factors that have statistically significan impact on prognosis.Conclusion.Combined approach with upfront surgery is one of the main treatment modalities for advanced oropharyngeal cancer. Modern reconstructive options and strict adherence to a proper surgical technique give a high chance for a valuable rehabilitation for the vast majority of patients. Scrupulous planning of the resection of the primary tumor based on modern imaging techniques and encouraging patients to complete all prescribed treatments are the main physician-related factors that influence survival outcome.
研究的目的是评估这种方法的结果,并确定可能影响这种方法有效性的因素。材料和方法。从2009年到2016年,72名年龄在42岁至77岁之间的III期和IV期患者接受了前期手术。解剖部位包括扁桃体34例(46%)、舌底24例(33%)和软腭14例(21%)。经颈保留下颌骨、下颌骨切除术和经口入路分别为42例(58%)、11例(15%)和7例(10%)。4例(5.5%)行全舌切除术。8例(11.5%)患者因肿瘤扩大需要行扩大喉切除术。30例(42%)患者咽部伤口可以初步闭合。其余42例患者行远端皮瓣重建。采用游离皮瓣(大腿前外侧皮瓣19例,前臂桡侧皮瓣10例)和轴向血供皮瓣(胸大肌皮瓣9例,锁骨上皮瓣4例)。T1 6例,T2 12例,T3 28例,T4 20例;62例患者n阳性:N1 - 10例,N2 - 51例,N3 - 1例。13例(18%)被诊断为手术边缘阳性,包括3例R2切除。45例(63.4%)患者完成了辅助放疗(伴或不伴化疗)。结果:术后早期死亡1例。其余患者(n = 71)平均随访27个月(1-94)。中位生存期为27个月(95% CI 11.5-42.5);3年总生存率为44%;34名仍然活着的病人中有33人能够口服食物。只有1例(2.9%)患者依赖胃造口管。单因素分析显示,阳性切缘(p <0.0001)和联合治疗的完整性(p <0.01)是影响晚期口咽癌预后的主要因素。结论:联合手术加前期手术是晚期口咽癌的主要治疗方式之一。现代重建选择和严格遵守适当的手术技术,为绝大多数患者提供了有价值的康复机会。基于现代影像技术的原发肿瘤切除的周密计划和鼓励患者完成所有规定的治疗是影响生存结果的主要医生相关因素。
{"title":"Surgery for advanced oropharyngeal cancer","authors":"A. Karpenko, R. Sibgatullin, A. A. Boyko, N. Chumanikhina, E. Y. Lomteva, M. V. Lavrova, M. Kostova, O. M. Nikolayeva","doi":"10.17650/2222-1468-2018-8-3-37-45","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-3-37-45","url":null,"abstract":"The study objectiveis to assess the results of this approach and identifications of factors that may influence the effectiveness of such an approach.Materials and methods. Since 2009 through 2016 72 patients with stage III and IV aged between 42 and 77 years underwent upfront surgery.Anatomical sites included 34 (46 %) tonsil, 24 (33 %) base of tongue and 14 (21 %) soft palate cases. Transcervical sparing the mandible,mandibulectomy and transoral approaches were used in 42 (58 %), 11 (15 %) and 7 (10 %) patient, respectively. Total glossectomy was performed in 4 (5.5 %) cases. Tumor extension necessitated extended laryngectomy in 8 patients (11.5 %). Primary closure of the pharyngeal wound was possible in 30 patients (42 %). Reconstruction with distant flaps was performed in the remaining 42 patients. Both free (anterolateral thigh – 19, radial forearm flap – 10) and flaps with axial blood supply (pectoralis major – 9, supraclavicular flap – 4) were used. There were 6 T1, 12 T2, 28 T3 and 20 T4 tumors; 62 patients were N-positive: N1 – 10 cases, N2 – 51, N3 – 1. Positive surgical margins were diagnosed in 13 cases (18 %) including 3 cases of R2 resection. Adjuvant radiation therapy with or without chemotherapy was completed in 45 patients (63.4 %). Survival was calculated according to Kaplan–Mayer method.Results.There was 1 death in early postoperative period. Mean follow-up for the remaining patients (n = 71) was 27 months (1–94). Median survival was 27 months (95 % CI 11.5–42.5); 3-year overall survival was 44 %; 33 out of 34 still alive patients are capable to take food orally. Only 1 (2.9 %) patient is gastrostomy tube dependent. Univariate analysis revealed that positive margins (p <0.0001) and completeness of combined treatment (p <0.01) are the main factors that have statistically significan impact on prognosis.Conclusion.Combined approach with upfront surgery is one of the main treatment modalities for advanced oropharyngeal cancer. Modern reconstructive options and strict adherence to a proper surgical technique give a high chance for a valuable rehabilitation for the vast majority of patients. Scrupulous planning of the resection of the primary tumor based on modern imaging techniques and encouraging patients to complete all prescribed treatments are the main physician-related factors that influence survival outcome.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fibrous dysplasia of the maxillofacial area: a 15-year retrospective study 颌面部纤维发育不良:一项15年回顾性研究
Q4 Medicine Pub Date : 2018-11-08 DOI: 10.17650/2222-1468-2018-8-3-12-20
A. Kugushev, A. Lopatin, S. Yasonov, M. Bolotin, Rogozhin Dv
{"title":"Fibrous dysplasia of the maxillofacial area: a 15-year retrospective study","authors":"A. Kugushev, A. Lopatin, S. Yasonov, M. Bolotin, Rogozhin Dv","doi":"10.17650/2222-1468-2018-8-3-12-20","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-3-12-20","url":null,"abstract":"","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"12-20"},"PeriodicalIF":0.0,"publicationDate":"2018-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49206233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Эффективность дистанционной лучевой терапии и таргетной терапии вандетанибом нерезектабельного и прогрессирующего медуллярного рака щитовидной железы 远程辐射疗法和targate疗法的有效性,包括非盈利性和渐进性甲状腺癌。
Q4 Medicine Pub Date : 2018-11-07 DOI: 10.17650/2222-1468-2018-8-3-72-76
A. D. Kaprin, S. A. Ivanov, F. Е. Sevryukov, I. S. Pimonova, P. A. Isaev, N. V. Severskaya, A. A. Ilyin, V. V. Polkin, D. Y. Siomin, S. V. Vasilkov, Derbugov Dn, Yu. A. Panaseikin, V. S. Medvedev
The study objective is to evaluate modern-era radiotherapy (external beam radiotherapy, EBRT) and target therapy (TT) outcomes for advanced medullary thyroid cancer (MTC). Materials and methods. Seventy eight consecutive patients with stage IV MTC were evaluated. All of them with relapsing locally advanced or metastatic MTC, 16 had clinically relevant mediastinal involvement, and 59 had distant metastasis; 26 patients received conformal EBRT or intensity-modulated radiotherapy in monomode, 16 patients – conformal EBRT with simultaneous TT with vandenanib, 36 patients – TT in monomode. Median EBRT dose was 60 Gy. Results. Kaplan–Meier estimates of the median overall survival rate was 14 months for radiotherapy in monomode, 48 months – for conformal EBRT + simultaneous TT with vandenanib, 50 months – for TT in monomode. EBRT and TT allows for significantly shorter periods (median 3.8 weeks), to relieve the symptoms of compression-mediated organs and structures of the neck and mediastinum than in the TT (median 10.2 weeks) (p <0.001). Conclusion. EBRT and TT provided durable locoregional disease control with limited morbidity.
本研究的目的是评估现代放射治疗(外束放疗,EBRT)和靶向治疗(TT)治疗晚期甲状腺髓样癌(MTC)的结果。材料和方法。对78例连续的IV期MTC患者进行了评估。所有患者均为复发的局部晚期或转移性MTC, 16例有临床相关纵隔受累,59例有远处转移;26例患者接受了适形EBRT或单模调强放疗,16例患者接受了适形EBRT,同时接受了范地尼治疗,36例患者接受了单模TT治疗。EBRT的中位剂量为60 Gy。结果。Kaplan-Meier估计单核细胞增多症放疗的中位总生存率为14个月,适形EBRT + vandenanib同时TT治疗的中位总生存率为48个月,单核细胞增多症TT治疗的中位总生存率为50个月。EBRT和TT的缓解颈部和纵隔压迫介导的器官和结构症状的时间(中位3.8周)明显短于TT(中位10.2周)(p <0.001)。结论。EBRT和TT提供了持久的局部疾病控制和有限的发病率。
{"title":"Эффективность дистанционной лучевой терапии и таргетной терапии вандетанибом нерезектабельного и прогрессирующего медуллярного рака щитовидной железы","authors":"A. D. Kaprin, S. A. Ivanov, F. Е. Sevryukov, I. S. Pimonova, P. A. Isaev, N. V. Severskaya, A. A. Ilyin, V. V. Polkin, D. Y. Siomin, S. V. Vasilkov, Derbugov Dn, Yu. A. Panaseikin, V. S. Medvedev","doi":"10.17650/2222-1468-2018-8-3-72-76","DOIUrl":"https://doi.org/10.17650/2222-1468-2018-8-3-72-76","url":null,"abstract":"The study objective is to evaluate modern-era radiotherapy (external beam radiotherapy, EBRT) and target therapy (TT) outcomes for advanced medullary thyroid cancer (MTC). Materials and methods. Seventy eight consecutive patients with stage IV MTC were evaluated. All of them with relapsing locally advanced or metastatic MTC, 16 had clinically relevant mediastinal involvement, and 59 had distant metastasis; 26 patients received conformal EBRT or intensity-modulated radiotherapy in monomode, 16 patients – conformal EBRT with simultaneous TT with vandenanib, 36 patients – TT in monomode. Median EBRT dose was 60 Gy. Results. Kaplan–Meier estimates of the median overall survival rate was 14 months for radiotherapy in monomode, 48 months – for conformal EBRT + simultaneous TT with vandenanib, 50 months – for TT in monomode. EBRT and TT allows for significantly shorter periods (median 3.8 weeks), to relieve the symptoms of compression-mediated organs and structures of the neck and mediastinum than in the TT (median 10.2 weeks) (p <0.001). Conclusion. EBRT and TT provided durable locoregional disease control with limited morbidity.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"8 1","pages":"72-76"},"PeriodicalIF":0.0,"publicationDate":"2018-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67776182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Opuholi Golovy i Sei
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1